 |
PDBsum entry 2zhr
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
2zhr
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase inhibitor
|
 |
|
Title:
|
 |
Crystal structure of bace1 in complex with om99-2 at ph 5.0
|
|
Structure:
|
 |
Beta-secretase 1. Chain: a, b. Fragment: catalytic domain, unp residues 45-454. Synonym: beta-site app cleaving enzyme 1, beta-site amyloid precursor protein cleaving enzyme 1, membrane-associated aspartic protease 2, memapsin-2, aspartyl protease 2, asp 2, asp2, bace1. Engineered: yes. Inhibitor om99-2. Chain: c, d.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: bace1. Expressed in: escherichia coli bl21. Expression_system_taxid: 511693. Synthetic: yes
|
|
Resolution:
|
 |
|
2.50Å
|
R-factor:
|
0.185
|
R-free:
|
0.240
|
|
|
Authors:
|
 |
H.Shimizu,N.Nukina
|
|
Key ref:
|
 |
H.Shimizu
et al.
(2008).
Crystal structure of an active form of BACE1, an enzyme responsible for amyloid beta protein production.
Mol Cell Biol,
28,
3663-3671.
PubMed id:
|
 |
|
Date:
|
 |
|
08-Feb-08
|
Release date:
|
22-Apr-08
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P56817
(BACE1_HUMAN) -
Beta-secretase 1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
501 a.a.
390 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Mol Cell Biol
28:3663-3671
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of an active form of BACE1, an enzyme responsible for amyloid beta protein production.
|
|
H.Shimizu,
A.Tosaki,
K.Kaneko,
T.Hisano,
T.Sakurai,
N.Nukina.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BACE1 (beta-secretase) is a transmembrane aspartic protease that cleaves the
beta-amyloid precursor protein and generates the amyloid beta peptide (Abeta).
BACE1 cycles between the cell surface and the endosomal system many times and
becomes activated interconvertibly during its cellular trafficking, leading to
the production of Abeta. Here we report the crystal structure of the
catalytically active form of BACE1. The active form has novel structural
features involving the conformation of the flap and subsites that promote
substrate binding. The functionally essential residues and water molecules are
well defined and play a key role in the iterative activation of BACE1. We
further describe the crystal structure of the dehydrated form of BACE1, showing
that BACE1 activity is dependent on the dynamics of a catalytically required
Asp-bound water molecule, which directly affects its catalytic properties. These
findings provide insight into a novel regulation of BACE1 activity and elucidate
how BACE1 modulates its activity during cellular trafficking.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2010).
Grading the commercial optical biosensor literature-Class of 2008: 'The Mighty Binders'.
|
| |
J Mol Recognit,
23,
1.
|
 |
|
|
|
|
 |
X.Chen,
O.Ghribi,
and
J.D.Geiger
(2010).
Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases.
|
| |
J Alzheimers Dis,
20,
S127-S141.
|
 |
|
|
|
|
 |
T.Tomita
(2009).
Secretase inhibitors and modulators for Alzheimer's disease treatment.
|
| |
Expert Rev Neurother,
9,
661-679.
|
 |
|
|
|
|
 |
O.Vanoni,
P.Paganetti,
and
M.Molinari
(2008).
Consequences of individual N-glycan deletions and of proteasomal inhibition on secretion of active BACE.
|
| |
Mol Biol Cell,
19,
4086-4098.
|
 |
|
|
|
|
 |
T.Sakurai,
K.Kaneko,
M.Okuno,
K.Wada,
T.Kashiyama,
H.Shimizu,
T.Akagi,
T.Hashikawa,
and
N.Nukina
(2008).
Membrane microdomain switching: a regulatory mechanism of amyloid precursor protein processing.
|
| |
J Cell Biol,
183,
339-352.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |